Browsing Tag
Tokyo
32 posts
Utsunomiya bear sightings shut 94 schools as Japan confronts rising wildlife attacks
A bear shut 94 Utsunomiya schools. Japan’s wildlife risk is moving from mountain villages into classrooms, homes and city streets.
June 10, 2026
Accenture’s Mitsubishi Chemical AI venture puts $ACN near a bigger enterprise automation test
Accenture and Mitsubishi Chemical are turning AI into back-office reinvention. Can RIX Business Partners prove enterprise automation at scale?
May 28, 2026
Alumni Ventures wants to bridge Japan and Silicon Valley. Can the timing get any better?
Japan has capital but needs global startup scale. Alumni Ventures’ Tokyo move could test whether U.S.-Japan venture bridges can finally work.
April 28, 2026
What Hilton (NYSE: HLT) sees in YOTEL that could reshape the next phase of lifestyle hotel expansion
Hilton has struck an exclusive deal with YOTEL. Read how the move could expand Select by Hilton, boost fee growth, and reshape lifestyle lodging.
March 30, 2026
Can Solana Company’s Pacific Backbone unlock Asia’s crypto liquidity engine?
Solana Company (NASDAQ: HSDT) launches its Pacific Backbone to expand APAC staking infrastructure. Discover what this means for investors.
February 23, 2026
Can Idemitsu Kosan and Source Energy redefine the space solar industry with next-gen CIGS arrays?
Find out how Idemitsu Kosan and Source Energy are co-developing CIGS-based solar arrays to solve space satellite power bottlenecks.
November 6, 2025
What NEC’s $2.9bn purchase of CSG Systems reveals about the future of telecom monetization
Discover how NEC’s $2.9 billion acquisition of CSG Systems is reshaping telecom software strategy—read the full analysis with institutional insights.
October 29, 2025
Raymond James’s GreensLedge buy: What this quiet deal says about Wall Street’s next credit cycle
Find out how Raymond James’s majority buy-in of GreensLedge could reshape its structured-credit advisory strength and open new fee opportunities in 2025.
October 16, 2025
Daiichi Sankyo (TSE: 4568) and AstraZeneca (NASDAQ: AZN) surge on Datroway’s historic first-line TNBC survival win
Find out how Datroway’s first-line TNBC survival win could rewrite chemotherapy-first playbooks and accelerate the ADC era in breast cancer—read the full analysis.
October 6, 2025
Investors brush off U.S. government shutdown drama—What this means for Asian stocks
Asian markets show resilience as U.S. shutdown looms, with investors weighing Fed policy, earnings, and data risks over Washington gridlock.
October 1, 2025